AKT1 and cancer: circRNA-SORE is transmitted to specific sensitive cells, which can prevent the breakdown of YBX1, a key cancer protein catalyzed by PRP19, and then inhibit the activation of related downstream factors (e.g., AKT, Raf1, ERK, etc.), thus spreading the resistance generated by chemotherapeutic drugs.